Skip to main content

Advertisement

SpringerLink
Log in

Geriatric Inflammatory Bowel Disease: Phenotypic Presentation, Treatment Patterns, Nutritional Status, Outcomes, and Comorbidity

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background and Aims

The U.S. population is aging and the burden of geriatric inflammatory bowel disease (IBD) patients has increased. Systematic data describing phenotypic presentation, treatment regimens, outcomes and comorbidities in elderly IBD patients is limited. We performed a retrospective observational study of IBD patients age ≥65 followed in a 20-hospital system to determine patterns of phenotypic presentation, treatment, polypharmacy, nutritional status and comorbidity.

Methods

Data were extracted from electronic medical record based on ICD-9 coding/indexed terms on Crohn’s disease (CD) and ulcerative colitis (UC) patients.

Results

A total of 393 geriatric IBD patients were identified (49.1% males; 50.9% females; 61.8% UC; 38.2% CD; 73.4 ± 6.6 years old). Younger age at diagnosis of CD (≤64) was associated with greater prevalence of small bowel surgeries (63.6%) compared with those diagnosed after age ≥65 (20.9%) (p < 0.005). Fistulizing/penetrating disease was frequent in patients diagnosed with CD at a younger age (43.6% compared to 7%) (p < 0.005). IBD maintenance treatment included: 44% 5-ASA agents; 31.6% maintenance prednisone (defined as ≥6 months treatment duration); 4.8% steroid suppositories; 5.6% 6MP/azathioprine; 1.3% methotrexate; 1.3% adalimumab; 1.3% infliximab; 9.4% loperamide/diphenoxylate/atropine; 0.5% had no IBD medications. Longer duration of CD disease correlated with vitamin B12, vitamin D and iron deficiency.

Conclusion

Geriatric patients diagnosed with CD earlier in life had greater small bowel involvement compared with new onset geriatric CD. There is low utilization of immunomodulator and biologic agents in geriatric IBD patients. Duration of CD correlates with nutrient deficiency. Prospective studies are warranted in this respect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yount RJ, Vries JK, Councill CD. The medical archival system: an information retrieval system based on distributed parallel processing. Inf Proc Manag. 1991;27:379–389.

    Article  Google Scholar 

  2. Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009;15:182–189.

    Article  PubMed  Google Scholar 

  3. Heresbach D, Alexandre JL, Bretagne JF, et al. Crohn’s disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol. 2004;16:657–664.

    Article  PubMed  Google Scholar 

  4. Page MJ, Poritz LS, Kunselman SJ, Koltun WA. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6:606–613.

    Article  PubMed  Google Scholar 

  5. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075–1079; discussion 1081–1090.

    Google Scholar 

  6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.

    Article  PubMed  CAS  Google Scholar 

  7. Cook JD. Clinical evaluation of iron deficiency. Semin Hematol. 1982;19:6–18.

    PubMed  CAS  Google Scholar 

  8. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3:383–389.

    PubMed  Google Scholar 

  9. Tal S, Shavit Y, Stern F, Malnick S. Association between vitamin B12 levels and mortality in hospitalized older adults. J Am Geriatr Soc. 2010;58:523–526.

    Article  PubMed  Google Scholar 

  10. Wilhelm-Leen ER, Hall YN, Deboer IH, Chertow GM. Vitamin D deficiency and frailty in older Americans. J Intern Med. 2010;268:171–180.

    Article  PubMed  CAS  Google Scholar 

  11. Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561–569.

    Article  PubMed  CAS  Google Scholar 

  12. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn’s disease. Inflamm Bowel Dis. 2008;14:217–223.

    Article  PubMed  Google Scholar 

  13. Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol. 2003;17:473–478.

    PubMed  Google Scholar 

  14. Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn’s disease. J Gastroenterol. 2004;39:527–533.

    Article  PubMed  CAS  Google Scholar 

  15. Thomson AB, Brust R, Ali MA, Mant MJ, Valberg LS. Iron deficiency in inflammatory bowel disease. Diagnostic efficacy of serum ferritin. Am J Dig Dis. 1978;23:705–709.

    Article  PubMed  CAS  Google Scholar 

  16. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin d status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:192–199.

    Article  PubMed  CAS  Google Scholar 

  17. Feagan BG, Vreeland MG, Larson LR, Bala MV. Annual cost of care for Crohn’s disease: a payor perspective. Am J Gastroenterol. 2000;95:1955–1960.

    Article  PubMed  CAS  Google Scholar 

  18. Robertson DJ, Grimm IS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2001;30:409–426.

    Article  PubMed  CAS  Google Scholar 

  19. Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol. 1996;31:417–427.

    Article  PubMed  CAS  Google Scholar 

  20. Softley A, Myren J, Clamp SE, Bouchier IA, Watkinson G, de Dombal FT. Inflammatory bowel disease in the elderly patient. Scand J Gastroenterol Suppl. 1988;144:27–30.

    PubMed  CAS  Google Scholar 

  21. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 2000;46:336–343.

    Google Scholar 

  22. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272–2280.

    Article  PubMed  Google Scholar 

  23. Surjan G. Questions on validity of international classification of diseases-coded diagnoses. Int J Med Inform. 1999;54:77–95.

    Article  PubMed  CAS  Google Scholar 

  24. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:731–743.

    Article  PubMed  Google Scholar 

  25. Grimm IS, Friedman LS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 1990;19:361–389.

    PubMed  CAS  Google Scholar 

  26. Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. Attract study group. Lancet 1999;354:1932–1939.

    Google Scholar 

  27. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med. 1989;111:641–649.

    PubMed  CAS  Google Scholar 

  28. O’Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn’s disease. Gastroenterology. 1991;101:39–46.

    PubMed  Google Scholar 

  29. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867–2878.

    Article  PubMed  CAS  Google Scholar 

  30. Gee MI, Grace MG, Wensel RH, Sherbaniuk R, Thomson AB. Protein-energy malnutrition in gastroenterology outpatients: increased risk in Crohn’s disease. J Am Diet Assoc. 1985;85:1466–1474.

    PubMed  CAS  Google Scholar 

  31. Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr. 1998;67:919–926.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Ms. Melissa Saul, Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA for providing us the data.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Medicine, Georgetown University School of Medicine, Washington, DC, USA

    Manie Juneja

  2. Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Leonard Baidoo, Marc B. Schwartz, Arthur Barrie III, Miguel Regueiro, Michael Dunn & David G. Binion

Authors
  1. Manie Juneja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonard Baidoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc B. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur Barrie III
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miguel Regueiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Dunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David G. Binion
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manie Juneja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juneja, M., Baidoo, L., Schwartz, M.B. et al. Geriatric Inflammatory Bowel Disease: Phenotypic Presentation, Treatment Patterns, Nutritional Status, Outcomes, and Comorbidity. Dig Dis Sci 57, 2408–2415 (2012). https://doi.org/10.1007/s10620-012-2083-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2083-x

Keywords

Search

Navigation